Head & Neck Cancers | Specialty

The OncLive Head and Neck Cancer condition center page is a comprehensive resource for clinical news and expert insights on treatment for patients with head and neck cancer. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research within head and neck cancer.

Dr. Mell Discusses Flaws in Risk Stratification for Head and Neck Cancer

February 26th 2018

Loren K. Mell, MD, assistant professor, Department of Radiation Medicine and Applied Sciences, University of California, San Diego School of Medicine, discusses flaws in the current model of risk stratification for patients with head and neck cancer.

Larotrectinib Update Shows Durable Responses in TRK-positive Cancers

February 22nd 2018

Larotrectinib (LOXO-101) induced durable responses in patients with TRK fusion–positive solid tumors, according to updated results for the novel pan-TRK inhibitor.

Dr. Bauml on HPV Vaccination for Head and Neck Cancer

February 22nd 2018

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses HPV vaccination for patients with HPV-related head and neck cancer.

Dr. Califano Discusses the Role of Surgery in Head and Neck Cancer

January 25th 2018

Joseph A. Califano, MD, professor of surgery, University of California, San Diego, discusses the role of surgery in head and neck cancer.

Moving Forward in Head and Neck Squamous Cell Cancer

January 25th 2018

Development of effective therapies for metastatic head and neck cancer has been challenging, and progress has been slow.

Dr. Sacco Discusses Multidisciplinary Care in Head and Neck Cancer

January 18th 2018

Assuntina G. Sacco, MD, assistant professor of medicine, medical oncologist, UC San Diego Health, discusses the importance of multidisciplinary care in the treatment of patients with head and neck cancer.

Dr. Bauml Discusses Biomarkers in Head and Neck Cancer

January 11th 2018

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses biomarker development for patients with head and neck cancer.

Dr. Mell on Factors of Risk Stratification in Head and Neck Cancer

January 5th 2018

Loren K. Mell, MD, assistant professor, Department of Radiation Medicine and Applied Sciences, University of California, San Diego School of Medicine, discusses factors that contribute to risk stratification and treatment of head and neck cancer.

Dabrafenib/Trametinib Combo Nears 70% Response in Thyroid Cancer

January 4th 2018

Nearly 7 in 10 patients with locally advanced or metastatic BRAF V600E–mutated anaplastic thyroid cancer responded to treatment with the combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib.

Dr. Cohen on Immunotherapy Combinations in Head and Neck Cancer

December 22nd 2017

Ezra Cohen, MD, associate director, Moores Cancer Center at the University of California, San Diego, discusses immunotherapy combinations in head and neck cancer.

Evolving Role of Surgery in Multidisciplinary Care for Head and Neck Cancer

December 18th 2017

Joseph A. Califano, MD, discusses how surgery factors into modern multidisciplinary care for patients with head and neck cancer.

Thyroid Cancer Landscape Advancing to Include Novel Surgical Techniques

December 16th 2017

Michael Bouvet, MD, highlights the evolving surgical options in the thyroid cancer field

Multidisciplinary Care Critical in Head and Neck Cancer

December 15th 2017

Assuntina G. Sacco, MD, discusses the importance of multidisciplinary care for patients with head and neck cancer.

Study Finds Significant Survival Disparities in HPV-related Cancer

December 9th 2017

Younger patients, women, and white patients with HPV-related cancers had superior survival at 5 years, indicating that increased HPV vaccination and better access to cancer screening and treatment are likely needed to reduce survival disparities

Dr. Bouvet Discusses the Diagnosis of Thyroid Cancer

December 8th 2017

Michael Bouvet, MD, professor of surgery, University of California, San Diego, discusses the diagnosis of thyroid cancer.

Number of Sexual Partners, Smoking Identified as Risk Factors for Oropharyngeal Cancer

December 8th 2017

While the incidence of HPV-related oropharyngeal cancer is increasing, the risk for developing the disease remains low for most people.

Dr. Daniels on Immunotherapy in Head and Neck Cancer

December 7th 2017

Gregory A. Daniels, MD, PhD, medical oncologist, associate professor of medicine, UC San Diego Health, discusses the role of immunotherapy for patients with head and neck cancer.

Dr. Califano on the Role of Multidisciplinary Care for Head and Neck Cancer

November 28th 2017

Joseph A. Califano, MD, professor of surgery, University of California, San Diego, discusses the role of multidisciplinary care for patients with head and neck cancer.

Expert Calls for a Change in the Staging of HNSCC

November 21st 2017

Loren K. Mell, MD, explains his research for risk-stratifying patients with head and neck cancer.

Dr. Gold on Approaching Patients with HPV-Positive Head and Neck Cancer

November 14th 2017

Kathryn A. Gold, MD, medical oncologist, associate professor of medicine, UC San Diego Heath, discusses approaching patients with HPV-positive head and neck cancer.